Manuscripts

Search by keyword, year, or author name.

Showing 1494 manuscripts.

Validation and application of a quantitative liquid chromatography tandem mass spectrometry assay for the analysis of rifapentine and 25-O-desacetyl rifapentine in human milk

Buyisile Mkhize, Tracy Kellermann, Jennifer Norman, Sandra Castel, Anton Joubert, Kelly E. Dooley, Jyoti S. Mathad, Lubbe Wiesner. Validation and application of a quantitative liquid chromatography tandem mass spectrometry assay for the analysis of rifapentine and 25-O-desacetyl rifapentine in human milk. Journal of Pharmaceutical and Biomedical Analysis. 2022. 215PMID: 35462285

Journal

Journal of Pharmaceutical and Biomedical Analysis

Study

IMPAACT 2001

Pharmacokinetics and Safety of Three Months of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention in Pregnant Women

Jyoti S Mathad, Rada Savic, Paula Britto, Priya Jayachandran, Lubbe Wiesner, Grace Montepiedra, Jennifer Norman, Nan Zhang, Ellen Townley, Nahida Chakhtoura, Sarah Bradford, Sandesh Patil, Stephanie Popson, Tsungai Chipato, Vanessa Rouzier, Deborah Langat, Amphan Chalermchockcharoentkit, Portia Kamthunzi, Amita Gupta, Kelly E Dooley, IMPAACT 2001 Study Team. Pharmacokinetics and Safety of Three Months of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention in Pregnant Women. Clinical Infectious Diseases. 2022. PMID: 34323955

Journal

Clinical Infectious Diseases

Study

IMPAACT 2001

Pharmacokinetics, safety, tolerability and antiviral activity of dolutegravir dispersible tablets in infants and children with HIV-1: results of the IMPAACT P1093 study, a phase I/II open-label trial

Theodore D. Ruel, Edward P. Acosta, Jessica P. Liu, Kathryn P. Gray, Kathleen George, Nicole Montañez, Stephanie Popson, Ann M. Buchanan, Mattie Bartlett, Dale Dayton, Patricia Anthony, Cynthia Brothers, Cynthia Vavro, Rajendra Singh, Lucy Koech, Tichaona Vhembo, Rohan Hazra, Ellen Townley, Andrew Wiznia, IMPAACT P1093 Team. Pharmacokinetics, safety, tolerability and antiviral activity of dolutegravir dispersible tablets in infants and children with HIV-1: results of the IMPAACT P1093 study, a phase I/II open-label trial. Lancet HIV. 2022. PMID: 35489377

Journal

Lancet HIV

Study

P1093

High Prevalence of Tuberculosis Infection and Disease in Child Household Contacts of Adults With Rifampin-resistant Tuberculosis.

Kim S, Wu X, Hughes MD, Upton C, Narunsky K, Mendoza-Ticona A, Khajenoori S, Gonzales P, Badal-Faesen S, Shenje J, Omoz-Oarhe A, Rouzier V, Garcia-Prats AJ, Demers AM, Naini L, Smith E, Churchyard G, Swindells S, Shah NS, Gupta A, Hesseling AC, ACTG A5300/IMPAACT 2003/PHOENix Feasibility Study Team. High Prevalence of Tuberculosis Infection and Disease in Child Household Contacts of Adults With Rifampin-resistant Tuberculosis.. Pediatric Infectious Disease Journal. 2022. 41: 194-202. PMID: 35239624

Journal

Pediatric Infectious Disease Journal

Study

IMPAACT 2003/ACTG 5300

Impact of CYP2B6 Genotype, TB Therapy and Formulation on Efavirenz Pharmacokinetics in Infants and Children Under 40 Months of Age

Mina Nikanjam, Lana Tran, Ellen G. Chadwick , Mutsa Bwakura-Dangarembizi, Carolyn Bolton Moore, Pearl Samson, Stephen A Spector, Nahida Chakhtoura, Patrick Jean-Philippe, Lisa Frenkel, Bonnie Zimmer, Alex Benns, Jennifer Libous, Edmund V. Capparelli. Impact of CYP2B6 Genotype, TB Therapy and Formulation on Efavirenz Pharmacokinetics in Infants and Children Under 40 Months of Age. AIDS. 2022. 36: 525-532. PMID: 34873089

Journal

AIDS

Study

P1070

Pharmacokinetics of atazanavir boosted with cobicistat in pregnant and postpartum women with HIV

Jeremiah Momper, Jiajia Wang, Alice Stek, David Shapiro, Kathleen Powis, Kathleen Powis, Martina Badell, Renee Browning, Nahida Chakhtoura, Kayla Denson, Kittipong Rungruengthanakit, Kathleen George, Edmund Capparelli, Mark Mirochnick, Brookie Best, IMPAACT P026s Protocol Team. Pharmacokinetics of atazanavir boosted with cobicistat in pregnant and postpartum women with HIV. Journal of Acquired Immune Deficiency Syndromes. 2022. 89: 303-309. PMID: 34732682

Journal

Journal of Acquired Immune Deficiency Syndromes

Study

P1026S

Emergence of Resistance in HIV-1 Integrase With Dolutegravir Treatment in a Pediatric Population From the IMPAACT P1093 Study

Cindy Vavro, Theodore Ruel, Andrew Wiznia, Nicole Montañez, Keith Nangle, Joseph Horton, Ann Buchanan, Eugene Stewart, Paul Palumbo. Emergence of Resistance in HIV-1 Integrase With Dolutegravir Treatment in a Pediatric Population From the IMPAACT P1093 Study. Antimicrobial Agents and Chemotherapy. 2022. 66: e0164521. PMID: 34694878

Journal

Antimicrobial Agents and Chemotherapy

Study

P1093

Site-Randomized Controlled Trial of a Combined Cognitive Behavioral Therapy and a Medication Management Algorithm for Treatment of Depression Among Youth Living With HIV in the United States

Brown, Chernoff, Kennard, Emslie, Lypen, Buisson, Weinberg, Whiteley, Traite, Krotje, Harriff, Townley, Bunch, Purswani, Shaw, Spector, Agwu, Shapiro. Site-Randomized Controlled Trial of a Combined Cognitive Behavioral Therapy and a Medication Management Algorithm for Treatment of Depression Among Youth Living With HIV in the United States. Journal of Acquired Immune Deficiency Syndromes. 2021. 88(5): 497-505. PMID: 34483297

Journal

Journal of Acquired Immune Deficiency Syndromes

Study

IMPAACT 2002